TRPV2 channel as a possible drug target for the treatment of heart failure

This publication has 94 references indexed in Scilit:

• The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses
  Frontiers in Immunology, 2013
• High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study
  Neuromuscular Disorders, 2012
• The Role of TRP Proteins in Mast Cells
  Frontiers in Immunology, 2012
• CaMKII in myocardial hypertrophy and heart failure
  Journal of Molecular and Cellular Cardiology, 2011
• Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
  Journal of Neuroinflammation, 2011
• Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
  JACC, 2010
• Role of Inotropic Agents in the Treatment of Heart Failure
  Circulation, 2010
• TRPV2 has a pivotal role in macrophage particle binding and phagocytosis
  Nature Immunology, 2010
• Probenecid, a gout remedy, inhibits pannexin 1 channels
  American Journal of Physiology-Cell Physiology, 2008
• Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
  American Journal of Physiology-Heart and Circulatory Physiology, 2007